The Horizon 3.0 Transcranial Magnetic Stimulation (TMS) Therapy System is a computerized, noninvasive medical device that directs electrical currents at different regions of the cerebral cortex. The ...

And also we found the significant effects in terms of ADAS-Cog [Alzheimer's Disease Assessment Scale-Cognitive Subscale], ...

MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has reported its financial and operational results for the third quarter of ...

The Horizon Inspire System. [Image courtesy of Magstim] Magstim announced today that the FDA cleared its next-generation ...

While traditional multistop options have served many shippers well, there is an even more impactful option on the market ...

In a small early trial using a transcranial magnetic stimulation procedure, scientists were able to target a key brain ...

Greenbrook Tms (GBNHF) has released an update. Greenbrook TMS Inc. shareholders have overwhelmingly approved the company’s acquisition by Neuronetics, Inc., paving the way for a significant corporate ...

One Robinson go-to-market strategy unlocks seamless shipper experience across TMS, 3PL, and 4PL services, addressing increased supply chain complexity with unprecedented agility EDEN PRAIRIE, Minn., ...

Analysts anticipate Edap TMS to report an earnings per share (EPS) of $-0.16. The market awaits Edap TMS's announcement, with ...

On November 8, 2024, Neuronetics (STIM)’ stockholders approved the previously announced acquisition of Greenbrook TMS in which ...